Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy

dc.contributor.authorÜstündag, B
dc.contributor.authorCanatan, H
dc.contributor.authorCinkilinc, N
dc.contributor.authorHalifeoglu, I
dc.contributor.authorBahcecioglu, IH
dc.date.accessioned2026-08-12T17:10:48Z
dc.date.issued2000
dc.departmentFırat Üniversitesi
dc.description.abstractInvolvement of complications is considered to be one of the major factors in the prognosis of diabetes mellitus (DM). Recent studies indicate that most diabetic complications such as nephropathy and hypertension are vascular-originated, Renin-angiotensin involvement, especially changes in ACE activity level, is considered to be a key factor since ACE converts angiotensin I to angiotensin II which is a potent vasoconstrictor and plays a vital role in the regulation of blood pressure. Our present study focused on ACE activity levels along with blood glucose and HbA(1c) levels in diabetic patients with (n = 18) or without (ii = 25) nephropathy as compared to control subjects (n = 25), Blood glucose levels were significantly higher in both diabetic groups compared to controls (p < 0.001). On the other hand. compared to controls, blood HbA(1c) levels were slightly higher in DM patients without complications whereas they were significantly increased in nephropatic DM patients (p < 0.001). There was a very strong increase (p < 0.001) at the level of ACE activity in both of the diabetic groups (with nephropathy: 47.11 +/- 3.70 U l(-1); without complications: 43.72 +/- 2.93 U l(-1): controls: 25.15 +/- 2.30 U l(-1)). ACE activity levels were also significantly higher in diabetic patients with nephropathy than in type II DM patients without complication (p < 0.01). Our results demonstrate that ACE activity levels are increased in diabetic patients. Additional significant increase in ACE activity levels in diabetic patients with complications such as nephropathy supports the hypothesis that ACE activity has an essential role in the development of complications in diabetes, Copyright (C) 2000 John Wiley &: Sons, Ltd.
dc.identifier.doi10.1002/(SICI)1099-0844(200001/03)18:1<23
dc.identifier.endpage28
dc.identifier.issn0263-6484
dc.identifier.issn1099-0844
dc.identifier.issue1
dc.identifier.orcid0000-0003-0787-0757
dc.identifier.orcid0000-0001-6621-2450
dc.identifier.pmid10686580
dc.identifier.scopus2-s2.0-0343882010
dc.identifier.scopusqualityQ3
dc.identifier.startpage23
dc.identifier.urihttps://doi.org/10.1002/(SICI)1099-0844(200001/03)18:1<23
dc.identifier.urihttps://hdl.handle.net/11508/50893
dc.identifier.volume18
dc.identifier.wosWOS:000085505000004
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofCell Biochemistry and Function
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectangiotensin converting enzyme (ACE)
dc.subjectdiabetes mellitus (DM)
dc.subjectnephropathy
dc.titleAngiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy
dc.typeArticle

Dosyalar